BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 33737298)

  • 1. Long-term Patterns of Excess Mortality among Endometrial Cancer Survivors.
    Anderson C; Bae-Jump VL; Broaddus RR; Olshan AF; Nichols HB
    Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1079-1088. PubMed ID: 33737298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis of Young Survivors of Gastric Cancer in China and the U.S.: Determining Long-Term Outcomes Based on Conditional Survival.
    Chen QY; Zhong Q; Wang W; Chen S; Li P; Xie JW; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Zheng HL; Liu ZY; Zheng CH; Peng JS; Zhou ZW; Huang CM
    Oncologist; 2019 Jun; 24(6):e260-e274. PubMed ID: 30470692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population-based study of cardiovascular disease mortality risk in US cancer patients.
    Sturgeon KM; Deng L; Bluethmann SM; Zhou S; Trifiletti DM; Jiang C; Kelly SP; Zaorsky NG
    Eur Heart J; 2019 Dec; 40(48):3889-3897. PubMed ID: 31761945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All-Cause and Cause-Specific Mortality Among Low-Risk Differentiated Thyroid Cancer Survivors in the United States.
    Tran TV; Schonfeld SJ; Pasqual E; Haymart MR; Morton LM; Kitahara CM
    Thyroid; 2024 Feb; 34(2):215-224. PubMed ID: 38149602
    [No Abstract]   [Full Text] [Related]  

  • 5. Late mortality among 5-year survivors of childhood cancer: A systematic review and meta-analysis.
    Moskalewicz A; Martinez B; Uleryk EM; Pechlivanoglou P; Gupta S; Nathan PC
    Cancer; 2024 May; 130(10):1844-1857. PubMed ID: 38271115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditional survival in pediatric malignancies: analysis of data from the Childhood Cancer Survivor Study and the Surveillance, Epidemiology, and End Results Program.
    Mertens AC; Yong J; Dietz AC; Kreiter E; Yasui Y; Bleyer A; Armstrong GT; Robison LL; Wasilewski-Masker K
    Cancer; 2015 Apr; 121(7):1108-17. PubMed ID: 25557134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of era of diagnosis on cause-specific late mortality among 77 423 five-year European survivors of childhood and adolescent cancer: The PanCareSurFup consortium.
    Byrne J; Schmidtmann I; Rashid H; Hagberg O; Bagnasco F; Bardi E; De Vathaire F; Essiaf S; Winther JF; Frey E; Gudmundsdottir T; Haupt R; Hawkins MM; Jakab Z; Jankovic M; Kaatsch P; Kremer LCM; Kuehni CE; Harila-Saari A; Levitt G; Reulen R; Ronckers CM; Maule M; Skinner R; Steliarova-Foucher E; Terenziani M; Zaletel LZ; Hjorth L; Garwicz S; Grabow D
    Int J Cancer; 2022 Feb; 150(3):406-419. PubMed ID: 34551126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory mortality of childhood, adolescent and young adult cancer survivors.
    Fidler MM; Reulen RC; Bright CJ; Henson KE; Kelly JS; Jenney M; Ng A; Whelan J; Winter DL; Frobisher C; Hawkins MM;
    Thorax; 2018 Oct; 73(10):959-968. PubMed ID: 29748251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with 5- and 10-year survival among a recent cohort of childhood cancer survivors (France, 2000-2015).
    Poulalhon C; Goujon S; Marquant F; Faure L; Guissou S; Bonaventure A; Désandes E; Rios P; Lacour B; Clavel J
    Cancer Epidemiol; 2021 Aug; 73():101950. PubMed ID: 34214767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Causes of death after testicular cancer diagnosis: a US population-based analysis.
    Wang Z; Li B; Xing J; Gong Z; Xu A; Wang Z
    BMC Urol; 2023 Sep; 23(1):144. PubMed ID: 37660082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A population-based study of COVID-19 mortality risk in US cancer patients.
    Mani KA; Wu X; Spratt DE; Wang M; Zaorsky NG
    J Natl Cancer Inst; 2024 Apr; ():. PubMed ID: 38621700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unravelling race inequities in cardiovascular disease mortality among cancer survivors: new insights and future directions.
    McCullough LE; Collin LJ; Statman M
    Int J Epidemiol; 2024 Apr; 53(3):. PubMed ID: 38684341
    [No Abstract]   [Full Text] [Related]  

  • 13. Optimising endometrial cancer survivorship through lifestyle change.
    Kitson SJ; Crosbie EJ
    Gynecol Oncol; 2023 Dec; 179():A1-A2. PubMed ID: 38103916
    [No Abstract]   [Full Text] [Related]  

  • 14. POLE and Mismatch Repair Status, Checkpoint Proteins and Tumor-Infiltrating Lymphocytes in Combination, and Tumor Differentiation: Identify Endometrial Cancers for Immunotherapy.
    Dong D; Lei H; Liu D; Bai H; Yang Y; Tang B; Li K; Liu J; Xu G; Xiao X
    Front Oncol; 2021; 11():640018. PubMed ID: 33816285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Adjuvant Therapy and Survival in Stage II-III Endometrial Cancer: Influence of Malignant Peritoneal Cytology.
    Matsuo K; Matsuzaki S; Nusbaum DJ; Roman LD; Wright JD; Harter P; Klar M
    Ann Surg Oncol; 2021 Nov; 28(12):7591-7603. PubMed ID: 33797002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a Metabolism-Related Signature for the Prediction of Survival in Endometrial Cancer Patients.
    Fan Y; Li X; Tian L; Wang J
    Front Oncol; 2021; 11():630905. PubMed ID: 33763366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparities in Hepatocellular Carcinoma Incidence, Stage, and Survival: A Large Population-Based Study.
    Flores YN; Datta GD; Yang L; Corona E; Devineni D; Glenn BA; Bastani R; May FP
    Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1193-1199. PubMed ID: 33737301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in the proportion of second or later primaries among all newly diagnosed malignant cancers.
    Anderson C; Mayer DK; Nichols HB
    Cancer; 2021 Aug; 127(15):2736-2742. PubMed ID: 33823564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy as a treatment strategy in advanced stage and recurrent endometrial cancer: review of current phase III immunotherapy clinical trials.
    Eskander RN; Powell MA
    Ther Adv Med Oncol; 2021; 13():17588359211001199. PubMed ID: 33796152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta-analysis.
    McAlpine JN; Chiu DS; Nout RA; Church DN; Schmidt P; Lam S; Leung S; Bellone S; Wong A; Brucker SY; Lee CH; Clarke BA; Huntsman DG; Bernardini MQ; Ngeow J; Santin AD; Goodfellow P; Levine DA; Köbel M; Kommoss S; Bosse T; Gilks CB; Talhouk A
    Cancer; 2021 Jul; 127(14):2409-2422. PubMed ID: 33793971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.